This Is the Best Pharma Stock to Invest $1,000 in Right Now

Eli Lilly (NYSE: LLY) is already a top pharmaceutical stock, and there are no signs that it's slowing down. With its dramatically successful medicines for type 2 diabetes and weight loss still near the start of their global market penetration, and with an array of follow-on drugs in development right now, the party for shareholders could continue for years and years.That's just one of several arguments for why it's worth investing $1,000 in Eli Lilly today. While an investment of that size won't make you rich, it could easily multiply in value over the next few years. Let's go through a handful of the drivers for this company's success and see why it's likely to continue succeeding.One of the key reasons to invest in Eli Lilly stock today is that it's acting so aggressively to capture demand for its recently commercialized medicines, and it's almost impossible to avoid the conclusion that management anticipates massive sales over the coming years.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool